Enhancer of zeste homologue 2 (EZH2) is a reliable immunohistochemical marker to differentiate malignant and benign hepatic tumors

• Egile Nagusiak: Hajósi-Kalcakosz Szofia (Egilea), Dezső Katalin (Egilea), Bugyik Edina (Egilea), Bödör Csaba (Egilea), Paku Sándor (Egilea), Pávai Zoltán (Egilea), Halász Judit (Egilea), Schlachter Krisztina (Egilea), Schaff Zsuzsa (Egilea), Nagy Péter (Egilea)
• Formatua: Liburua
• Argitaratua: BMC, 2012-07-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

<p>Abstract</p> <p>Background</p> <p>The immunohistochemical demonstration of Enhancer of zeste homologue 2 (EZH2) proved to be a useful marker in several tumor types. It has been described to distinguish reliably hepatocellular carcinomas from liver adenomas and other...